GRILLI, GIADA
 Distribuzione geografica
Continente #
NA - Nord America 433
EU - Europa 381
AS - Asia 164
AF - Africa 26
Totale 1.004
Nazione #
US - Stati Uniti d'America 432
IT - Italia 117
SE - Svezia 64
VN - Vietnam 58
GB - Regno Unito 56
DE - Germania 47
CN - Cina 42
IE - Irlanda 25
AT - Austria 24
IN - India 24
SG - Singapore 18
TG - Togo 13
JO - Giordania 10
BG - Bulgaria 9
RU - Federazione Russa 7
CZ - Repubblica Ceca 6
IL - Israele 6
CI - Costa d'Avorio 5
EE - Estonia 5
FR - Francia 5
UA - Ucraina 5
ZA - Sudafrica 5
ES - Italia 4
CH - Svizzera 3
FI - Finlandia 3
JP - Giappone 3
NG - Nigeria 3
CA - Canada 1
GR - Grecia 1
HK - Hong Kong 1
IR - Iran 1
SA - Arabia Saudita 1
Totale 1.004
Città #
Chandler 86
Dong Ket 58
Southend 50
Fairfield 37
Redmond 35
Ashburn 32
Bologna 28
Seattle 28
Dublin 25
Vienna 24
Woodbridge 22
Princeton 20
Houston 19
Cambridge 15
Lomé 13
Wilmington 13
Singapore 11
Amman 10
Sofia 9
Bremen 7
Moncalieri 7
Nanjing 7
Los Angeles 6
Medford 6
Pelhrimov 6
Rehovot 6
Abidjan 5
Jinan 5
Westminster 5
Ann Arbor 4
Beijing 4
Florence 4
Naples 4
Olalla 4
Seville 4
Abeokuta 3
Berlin 3
Dearborn 3
Helsinki 3
Shenyang 3
Turin 3
Bern 2
Des Moines 2
Formigine 2
Haikou 2
Hyderabad 2
Imola 2
Jiaxing 2
Manchester 2
Modena 2
Redwood City 2
Rome 2
Saint Petersburg 2
Saitama 2
Taurianova 2
Vicenza 2
Argelato 1
Boardman 1
Boydton 1
Büdelsdorf 1
Bühl 1
Caserta 1
Cedar Knolls 1
Central 1
Chatsworth 1
Cogollo del Cengio 1
Forlì 1
Fremont 1
Genova 1
Hamburg 1
Hebei 1
Kilburn 1
La Canada Flintridge 1
Lanzhou 1
Molinella 1
Norwalk 1
Pune 1
Reggio Nell'emilia 1
Riyadh 1
San Diego 1
San Francisco 1
San Jose 1
San Mateo 1
Taiyuan 1
Tianjin 1
Tokyo 1
Toronto 1
Ulan-ude 1
Verona 1
Zhengzhou 1
Totale 701
Nome #
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience 181
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy 136
Modulation of ERBB signaling from tissue homeostasis to cancer progression 110
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial) 108
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 106
Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling 87
A putative role for interleukin 1 pathway in resistance to EGFR blockade 83
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors 61
Unveiling the role of interleukine-1 Receptor in response to EGFR blockade 58
Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma 56
Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: A meta-analysis 49
Totale 1.035
Categoria #
all - tutte 3.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 0 3 2 2 4 7 12 10 9 2 4 2
2020/2021238 10 19 23 0 44 29 10 6 11 8 7 71
2021/2022218 8 4 0 8 14 13 5 29 20 16 51 50
2022/2023321 33 49 17 54 26 20 12 16 58 9 15 12
2023/202492 8 25 2 9 8 25 2 2 2 5 3 1
2024/202526 22 4 0 0 0 0 0 0 0 0 0 0
Totale 1.035